Overview

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The sponsor electively terminated the study because the risk mitigation measures, deemed necessary after an unforeseen safety event, could not be effectively implemented within this protocol while maintaining study timelines within a reasonable time frame.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
EMD Serono
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Criteria
Inclusion Criteria:

- Male or female subjects, ≥ 18 years of age, who provide written informed consent

- Subjects must have a diagnosis of SLE satisfying ≥ 4 of 11 ACR criteria, and must have
had a renal biopsy during screening or within the previous 18 months demonstrating
class III (A or A/C), IV (A or A/C), V, or concomitant III/V or IV/V LN as defined by
the International Society of Nephrology/Renal Pathology Society (ISN/RPS).

- Subjects must have a urine protein: creatinine ratio ≥ 2 mg/mg (≥ 226.2 mg/mmol), and
either a positive test for antinuclear antibody (ANA) (HEp-2 ANA ≥ 1:80) and/or
anti-double stranded deoxyribonucleic acid (dsDNA) (≥ 30 IU/mL) at screening.

- Subjects must have started induction therapy for LN at least 5 months prior to Trial
Day 1, be considered to have received continuous treatment for LN during the 5 months
prior to Trial Day 1, and have received a stable dose of MMF ≥ 1 g/day, with or
without corticosteroids, for at least 8 weeks prior to Trial Day 1.

Exclusion Criteria:

- Recent changes in immunosuppressant, ACD inhibitors for ARBs

- Use of azathioprine, cyclosporine, tacrolimus, or cyclophosphamide or other biologics
within 8 weeks prior to Trial Day 1.

- Serum IgG < 6 g/L

- Estimated Glomerular Filtration Rate (GFR) ≤ 30 mL/min per 1.73 m2

- History of Demyelinating Disease

- Significant Hematuria and/or Proteinuria due to a reason(s) other than LN. Evaluation
should be done according to the local standard of care

- Breast feed or pregnancy

- Legal Incapacity or limited legal capacity